Transferrin coupled liposomes for enhanced brain delivery of doxorubicin

Vascular Disease Prevention

Volumn 4, Issue 1, 2007, Pages 31-38

  Soni, Vandana ^a   Kohli, Dharam V ^a   Jain, Sanjay K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Brain delivery; Doxorubicin; Liposome; Transferrin

Indexed keywords

DOXORUBICIN; LIPOSOME; PENTETATE TECHNETIUM TC 99M; TRANSFERRIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG STABILITY; DRUG UPTAKE; ENCAPSULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

EID: 33846855837     PISSN: 15672700     EISSN: None     Source Type: Journal    
DOI: 10.2174/156727007779802769     Document Type: Article

References (19)

1. Pardridge WM. In: Taylor MD & Amidon GL, Ed, Peptide based drug design, Washington DC, American chemical society 1995; 265-96.
2. Neuwelt EE, Goldmen DI, Dahlborg SA, Brazil R. Primary CNS lymphoma treated with osmotic blood brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991; 9: 1580-1590.
3. Inamura T, Blake KI, Bradykinin selectivity opens blood tumor barriers in experimental brain tumors. J Cereb Blood Flow Metab 1994; 14: 862-870.
4. Pardridge WM. Vector mediated peptide drug delivery to brain. Adv Drug Del Rev 1995; 15: 109-146.
5. Soni VS, Kohli DV, Jain SK. Transferrin-coupled liposomes as drug delivery carrier for brain targeting of 5-fluorouracil. J Drug Target 2005; 13: 245-50.
6. Strom G, Koppenhagen A, Heeremans A, Vingerhoeds M, Woodle MC, Crommelin DJA. Novel developments in liposomal delivery of peptides and proteins. J Contol Rel 1995; 36: 19-24.
7. Simoes S, Fonseca C, Pedroso de Lima MC, Duzgunes N. In: Arshde R, Ed, Trigger sensitive assemblies and particulates. London, Citus Books 2005; 145-68.
8. Zhong MQ, Hongyan L, Hongzhe U, Kwokping H. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002; 54: 561-587.
9. Cheng Y, Zak O, Alsen P, Harrison SC, Watz T. Structure of the human transferrin receptor-transferrin complex. Cell 2004; 116: 565-76.
10. 99mTc] technetium-labeled liposomes in normal and tumor bearing rats. Biochem Soc Trans 1977; 5: 290-99.
11. Theobald AE. In: Sampson CB, Ed, Textbook of radiopharmacy, New York, Gorden and Breach 1990; 127-128.
12. Koukourakis MI, Giatromanolaki A, Archimandritis SC, et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J Clin Oncol 1999; 17: 3512-21.
13. Bangham AD. Membrane model with phospholipids. Prog Biophy Mol Biol 1968; 18: 29-39.
14. Bradford MA. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
15. Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. J Anal Biochem 1978; 90: 803-09.
16. Chin DL, Lum BL, Sikic BI. Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 5: 259-69.
17. Litzinger DC, Buiting AM, Van Rooijen N, Huang L. Effect of liposome size on the circulation time and intra organ distribution of amphipathic poly (ethylene glycol)-containing liposomes. Biochim Biophys Acta 1994; 119: 99-107.
18. Abe T, Hasegawa S, Taniguchi K, et al. Possible involvement of multidrug-resistance-association protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and Adriamycin in glioma cells. Int J Cancer 1994; 58: 860-64.
19. Mabeuf-Gueye C, Broxterman HJ, Dubru F, Priebe W, Garnier Suillerot A. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells. Pharmacol 1997; 53: 141-47.